Cerus Corporation (NASDAQ: CERS) shares rose 8.8% to $6.20 as the company announced an agreement Sunday with the BARDA for potential funding of up to $180 million to advance INTERCEPT red blood cell program. Share volume was 1.9 million, compared to an all-day average of one million
